By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Helicos BioSciences said Tuesday after the close of the market that as part of its ongoing restructuring plan it will cut another 14 positions from the firm as it aims to reduce its operating costs.

In addition, it disclosed that Chairman Stanley Lapidus has stepped down from his post but will remain a member of the board of directors.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: co-evolutionary signatures of insect hosts and bacterial symbionts, distinct transcript isoforms of high-grade ovarian cancer, and more.

Adam Rutherford discusses genetic genealogy at the Guardian.

Portions of the US 21st Century Cures Act are raising some safety concerns.

David Dobbs writes at Buzzfeed that genomics has delivered little on its promises.